BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3384 related articles for article (PubMed ID: 7399746)

  • 1. The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients.
    de Vries JE; Mendelsohn J; Bont WS
    Int J Cancer; 1980 Jan; 25(1):73-84. PubMed ID: 7399746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M; Vilien M; Pape GR; Perlmann P
    Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
    Richter M; Kazaniwsky N
    Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte cytotoxicity of patients developing multiple primary melanomas.
    Mukherji B; Dayal Y
    Cancer; 1980 Oct; 46(7):1566-71. PubMed ID: 6968241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients.
    Yanagawa E; Uchida A; Kokoschka EM; Micksche M
    Cancer Immunol Immunother; 1984; 16(3):131-6. PubMed ID: 6200209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
    de Vries JE; Rümke P
    Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors.
    de Vries JE; Meyering M; van Dongen A; Rümke P
    Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
    Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
    Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
    Nishiya K; Horwitz DA
    J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines.
    Chang ZL; Hoffman T; Stevenson HC; Trinchieri G; Herberman RB
    Scand J Immunol; 1983 Nov; 18(5):451-9. PubMed ID: 6648368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of target cells, monocytes, and Fc receptor-bearing lymphocytes in human spontaneous cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity.
    de Vries JE; Mendelsohn J; Bont WS
    J Immunol; 1980 Jul; 125(1):396-405. PubMed ID: 7381206
    [No Abstract]   [Full Text] [Related]  

  • 15. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for monocytes in the spontaneous cytotoxic effects of human lymphocytes against non-lymphoid target cells.
    de Vries JE; Mendelsohn J; Bont WS
    Nature; 1980 Feb; 283(5747):574-6. PubMed ID: 7354840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte mediated cytotoxic activity against melanoma.
    te Velde AA; Figdor CG
    Melanoma Res; 1992; 1(5-6):303-9. PubMed ID: 1422187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
    Wersäll P; Masucci G; Mellstedt H
    Cancer Immunol Immunother; 1991; 33(1):45-9. PubMed ID: 2021957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells?
    Pross HF; Baines MG; Jondal M
    Int J Cancer; 1977 Sep; 20(3):353-8. PubMed ID: 903188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody dependent cellular cytotoxicity and mitogen responsiveness of human peripheral blood lymphocytes differing in avidity for sheep erythrocytes.
    Jónsdóttir I; Dillner-Centerlind ML; Perlmann H; Perlmann P
    Scand J Immunol; 1979; 10(6):525-33. PubMed ID: 542806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 170.